Strides Pharma Science Limited (BOM:532531)

Market Cap	79.05B +48.6%
Revenue (ttm)	47.26B +3.2%
Net Income	5.11B -85.5%
EPS	55.49 -85.5%
Shares Out	n/a
PE Ratio	15.46
Forward PE	12.53
Dividend	4.00 (0.45%)
Ex-Dividend Date	Jul 22, 2025

Volume	3,264
Average Volume	33,026
Open	871.65
Previous Close	877.60
Day's Range	862.15 - 879.65
52-Week Range	551.00 - 1,024.90
Beta	n/a
RSI	46.75
Earnings Date	Jan 30, 2026

About Strides Pharma Science

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under th...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 3,301
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532531